Camós-Carreras Anna, Figueras-Roca Marc, Albà-Arbalat Salut, Alcubierre Rafel, Saint-Gerons Marta, Sánchez-Dalmau Bernardo
Ophthalmology Department (AC-C, MF-R, SA-A, RA, BS-D), Seu Maternitat, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain; Faculty of Medicine and Health Sciences (AC-C, SA-A, BS-D), Universitat de Barcelona, Barcelona, Spain; Fundació Per La Recerca Biomèdica-IDIBAPS (MF-R, SA-A, BS-D), Barcelona, Spain; and Ophthalmology Department (MS-G), Consorci Mar Parc de Salut de Barcelona, Barcelona, Spain.
J Neuroophthalmol. 2024 Nov 14;45(3):273-277. doi: 10.1097/WNO.0000000000002294.
Autosomal Dominant Optic Atrophy (ADOA) is a hereditary optic neuropathy characterized by retinal ganglion cell degeneration and optic nerve fiber loss. This study examined the correlation between clinical and structural parameters in patients with ADOA using optical coherence tomography (OCT) and explored potential clinical biomarkers.
A cross-sectional, case-control observational study included 27 patients with ADOA and 27 age- and sex-matched healthy controls. Clinical examinations, OCT imaging, and OCT angiography (OCTA) were performed. Statistical analyses were conducted to establish correlations between clinical and OCT parameters.
Patients with ADOA exhibited gradual bilateral vision loss, central scotomas, and optic disc pallor. Structural OCT analysis revealed significant reductions in central macular thickness, macular volume, ganglion cell complex (GCC), and peripapillary retinal nerve fiber layer compared with controls. Correlation analysis demonstrated associations between worsening clinical parameters (best corrected visual acuity, Sloan Letters Low Contrast Chart 25%, Pseudoisochromatic Test) and increased OCT damage (structural and OCTA). GCC emerged, at least at exploratory terms, as the most important clinical biomarker in patients with ADOA given its multiple positive functional associations, while OCTA parameters correlated with visual field defects.
Our study revealed significant correlations between clinical and structural parameters in patients with ADOA, highlighting the importance of OCT in assessing disease severity. GCC measurement shows promise as a clinical biomarker, aiding in disease monitoring. OCTA parameters offer potential early biomarkers for vascular changes. These findings contribute to understanding ADOA pathophysiology and may improve patient diagnosis and management. Further research is warranted to validate these findings and explore potential therapeutic interventions.
常染色体显性遗传性视神经萎缩(ADOA)是一种遗传性视神经病变,其特征为视网膜神经节细胞变性和视神经纤维丧失。本研究使用光学相干断层扫描(OCT)检查了ADOA患者临床参数与结构参数之间的相关性,并探索了潜在的临床生物标志物。
一项横断面病例对照观察性研究纳入了27例ADOA患者以及27例年龄和性别匹配的健康对照者。进行了临床检查、OCT成像和OCT血管造影(OCTA)。进行统计分析以确定临床参数与OCT参数之间的相关性。
ADOA患者表现出逐渐的双侧视力丧失、中心暗点和视盘苍白。结构OCT分析显示,与对照组相比,中心黄斑厚度、黄斑体积、神经节细胞复合体(GCC)和视乳头周围视网膜神经纤维层均显著降低。相关性分析表明,临床参数恶化(最佳矫正视力、Sloan字母低对比度图表25%、假同色试验)与OCT损伤增加(结构和OCTA)之间存在关联。鉴于其多种积极的功能关联,至少在探索性层面上,GCC成为ADOA患者最重要的临床生物标志物,而OCTA参数与视野缺损相关。
我们的研究揭示了ADOA患者临床参数与结构参数之间存在显著相关性,突出了OCT在评估疾病严重程度方面的重要性。GCC测量有望作为一种临床生物标志物,有助于疾病监测。OCTA参数为血管变化提供了潜在的早期生物标志物。这些发现有助于理解ADOA的病理生理学,并可能改善患者的诊断和管理。有必要进行进一步研究以验证这些发现并探索潜在的治疗干预措施。